893
Views
2
CrossRef citations to date
0
Altmetric
Review

The Application of Skin Care Product in Melasma Treatment

, , &
Pages 1165-1171 | Published online: 07 Sep 2021

References

  • Rajanala S, Maymone M, Vashi NA. Melasma pathogenesis: a review of the latest research, pathological findings, and investigational therapies. Dermatol Online J. 2019;25(10):13030. doi:10.5070/D32510045810
  • Shankar K, Godse K, Aurangabadkar S, et al. Evidence-based treatment for melasma: expert opinion and a review. Dermatol Ther (Heidelb). 2014;4(2):165–186. doi:10.1007/s13555-014-0064-z
  • Li L, Li H, Wei L, et al. Guide to the application of skin care products in dermatology. Chin J Dermatol Venereol. 2015;29(06):553–555.
  • Lee DJ, Lee J, Ha J, et al. Defective barrier function in melasma skin. J Eur Acad Dermatol Venereol. 2012;26(12):1533–1537.
  • Rongya Y, Jin C. Consensus of experts on phototherapy and repair of chloasma. J Pract Dermatol. 2020;13(02):65–69.
  • Shanshan H, Li L, Li H. Application of medical skin care products in dermatology. Skin Dis and Venereal Dis. 2008;(03):13–14.
  • Kang WH, Yoon KH, Lee ES, et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146(2):228–237. doi:10.1046/j.0007-0963.2001.04556.x
  • Speeckaert R, Van Gele M, Speeckaert MM, et al. The biology of hyperpigmentation syndromes. Pigment Cell Melanoma Res. 2014;27(4):512–524. doi:10.1111/pcmr.12235
  • Kang HY, Suzuki I, Lee DJ, et al. Transcriptional profiling shows altered expression of wnt pathway- and lipid metabolism-related genes as well as melanogenesis-related genes in melasma. J Invest Dermatol. 2011;131(8):1692–1700. doi:10.1038/jid.2011.109
  • Enomoto A, Yoshihisa Y, Yamakoshi T, et al. UV-B radiation induces macrophage migration inhibitory factor-mediated melanogenesis through activation of protease-activated receptor-2 and stem cell factor in keratinocytes. Am J Pathol. 2011;178(2):679–687. doi:10.1016/j.ajpath.2010.10.021
  • Esposito A, Brianezi G, de Souza NP, et al. Exploring pathways for sustained melanogenesis in facial melasma: an immunofluorescence study. Int J Cosmet Sci. 2018;40(4):420–424. doi:10.1111/ics.12468
  • Yoshida M, Takahashi Y, Inoue S. Histamine induces melanogenesis and morphologic changes by protein kinase A activation via H2 receptors in human normal melanocytes. J Invest Dermatol. 2000;114(2):334–342. doi:10.1046/j.1523-1747.2000.00874.x
  • Malaviya R, Morrison AR, Pentland AP. Histamine in human epidermal cells is induced by ultraviolet light injury. J Invest Dermatol. 1996;106(4):785–789. doi:10.1111/1523-1747.ep12346356
  • Inomata S, Matsunaga Y, Amano S, et al. Possible involvement of gelatinases in basement membrane damage and wrinkle formation in chronically ultraviolet B-exposed hairless mouse. J Invest Dermatol. 2003;120(1):128–134. doi:10.1046/j.1523-1747.2003.12021.x
  • Kwon SH, Hwang YJ, Lee SK, et al. Heterogeneous pathology of melasma and its clinical implications. Int J Mol Sci. 2016;17(6):824. doi:10.3390/ijms17060824
  • Merle C, Laugel C, Baillet-Guffroy A. Effect of UVA or UVB irradiation on cutaneous lipids in films or in solution. Photochem Photobiol. 2010;86(3):553–562. doi:10.1111/j.1751-1097.2009.00690.x
  • Baldwin H, Santoro F, Lachmann N, et al. A novel moisturizer with high sun protection factor improves cutaneous barrier function and the visible appearance of rosacea-prone skin. J Cosmet Dermatol. 2019;18(6):1686–1692. doi:10.1111/jocd.12889
  • Sarkar R, Ghunawat S, Narang I, et al. Role of broad-spectrum sunscreen alone in the improvement of melasma area severity index (MASI) and melasma quality of life index in melasma. J Cosmet Dermatol. 2019;18(4):1066–1073.
  • Lakhdar H, Zouhair K, Khadir K, et al. Evaluation of the effectiveness of a broad-spectrum sunscreen in the prevention of chloasma in pregnant women. J Eur Acad Dermatol Venereol. 2007;21(6):738–742. doi:10.1111/j.1468-3083.2007.02185.x
  • Fatima S, Braunberger T, Mohammad TF, et al. The role of sunscreen in melasma and postinflammatory hyperpigmentation. Indian J Dermatol. 2020;65(1):5–10. doi:10.4103/ijd.IJD_295_18
  • Boukari F, Jourdan E, Fontas E, et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial. J Am Acad Dermatol. 2015;72(1):189–190. doi:10.1016/j.jaad.2014.08.023
  • D’Mello SA, Finlay GJ, Baguley BC, et al. Signaling pathways in melanogenesis. Int J Mol Sci. 2016;17(7):1144. doi:10.3390/ijms17071144
  • Sarkar R, Arora P, Garg KV. Cosmeceuticals for hyperpigmentation: what is available? J Cutan Aesthet Surg. 2013;6(1):4–11. doi:10.4103/0974-2077.110089
  • Telang PS. Vitamin C in dermatology. Indian Dermatol Online J. 2013;4(2):143–146. doi:10.4103/2229-5178.110593
  • Bronzina E, Clement A, Marie B, et al. Efficacy and tolerability on melasma of a topical cosmetic product acting on melanocytes, fibroblasts and endothelial cells: a randomized comparative trial against 4% hydroquinone. J Eur Acad Dermatol Venereol. 2020;34(4):897–903. doi:10.1111/jdv.16150
  • Draelos ZD. Cosmeceuticals: what’s real, what’s not. Dermatol Clin. 2019;37(1):107–115. doi:10.1016/j.det.2018.07.001
  • Nolan K, Marmur E. Moisturizers: reality and the skin benefits. Dermatol Ther. 2012;25(3):229–233. doi:10.1111/j.1529-8019.2012.01504.x
  • Xiaofeng H, Yinjuan W, Meihua G, et al. Observation on the efficacy of Pang’s flawless transparent day cream in improving chloasma and its skin barrier function. Skin Dis Venereal Dis. 2014;36(03):125–128.
  • Elias PM, Menon G, Wetzel BK, et al. Evidence that stress to the epidermal barrier influenced the development of pigmentation in humans. Pigment Cell Melanoma Res. 2009;22(4):420–434. doi:10.1111/j.1755-148X.2009.00588.x
  • Kim SJ, Park JY, Shibata T, et al. Efficacy and possible mechanisms of topical tranexamic acid in melasma. Clin Exp Dermatol. 2016;41(5):480–485. doi:10.1111/ced.12835
  • Na JI, Shin JW, Choi HR, et al. Resveratrol as a multifunctional topical hypopigmenting agent. Int J Mol Sci. 2019;20(4):956. doi:10.3390/ijms20040956
  • Tadokoro T, Bonte F, Archambault JC, et al. Whitening efficacy of plant extracts including orchid extracts on Japanese female skin with melasma and lentigo senilis. J Dermatol. 2010;37(6):522–530. doi:10.1111/j.1346-8138.2010.00897.x
  • Dun H, Fanglan W, Xiaolan X, et al. Study on the therapeutic effect and mechanism of arbutin on yellow brown spot rat model. Chin J Modern Med. 2018;28(34):6–10.
  • Levin J, Momin SB. How much do we really know about our favorite cosmeceutical ingredients? J Clin Aesthet Dermatol. 2010;3(2):22–41.
  • Sanchez M, Gonzalez-Burgos E, Iglesias I, et al. Pharmacological update properties of aloe vera and its major active constituents. Molecules. 2020;25(6):1324. doi:10.3390/molecules25061324
  • Ghafarzadeh M, Eatemadi A. Clinical efficacy of liposome-encapsulated Aloe vera on melasma treatment during pregnancy. J Cosmet Laser Ther. 2017;19(3):181–187. doi:10.1080/14764172.2017.1279329
  • Xiaofeng H, Haiyang L, Meihua G, et al. Studies on the effects of Camellia oleifera, Euphorbia angustifolia, Mulberry Fruit and Chonglou on the proliferative activity and tyrosinase of melanocytes. Chin J Dermatol. 2015;48(02):133–136.
  • Atallah C, Charcosset C, Greige-Gerges H. Challenges for cysteamine stabilization, quantification, and biological effects improvement. J Pharm Anal. 2020;10(6):499–516. doi:10.1016/j.jpha.2020.03.007
  • Wenli L, Jun C, Xiuqiong X. Clinical observation on the treatment of chloasma with the essence of green thorn fruit, purslane, Dianshan tea and Panax notoginseng. Skin Dis Venereal Dis. 2020;542(06):789–792.
  • Czarnowicki T, Malajian D, Khattri S, et al. Petrolatum: barrier repair and antimicrobial responses underlying this “inert” moisturizer. J Allergy Clin Immunol. 2016;137(4):1091–1102. doi:10.1016/j.jaci.2015.08.013
  • Korponyai C, Szel E, Behany Z, et al. Effects of locally applied glycerol and xylitol on the hydration, barrier function and morphological parameters of the skin. Acta Derm Venereol. 2017;97(2):182–187. doi:10.2340/00015555-2493
  • Ibrahim ZA, Gheida SF, El MG, et al. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma. J Cosmet Dermatol. 2015;14(2):113–123. doi:10.1111/jocd.12143
  • Meng HM, Li L. The effect and clinical application of fruit acid.J. Dermatol Venereol. 2014;36(03):155–157.
  • Polnikorn N. Treatment of refractory melasma with the MedLite C6 Q-switched Nd: YAGlaser and alpha arbutin: a prospective study. J Cosmet Laser Ther. 2010;12(3):126–131. doi:10.3109/14764172.2010.487910
  • Danby SG, Andrew PV, Brown K, et al. An investigation of the skin barrier restoring effects of a cream and lotion containing ceramides in a multi-vesicular emulsion in people with dry, eczema-prone, skin: the RESTORE study phase 1. Dermatol Ther (Heidelb). 2020;10(5):1031–1041. doi:10.1007/s13555-020-00426-3
  • Soliman MM, Ramadan SA, Bassiouny DA, et al. Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study. J Cosmet Dermatol. 2007;6(2):89–94. doi:10.1111/j.1473-2165.2007.00302.x
  • Qin P, Jie Z, Cheng Y, et al. Effect of medical skin care products on skin barrier function after skin activation with fruit acid. 2013 National Annual meeting of Integrated traditional Chinese and Western Medicine on Dermatological Diseases; Xiamen, Fujian, China; 2013.